DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Outcome for Outcome Of Board Meeting - Audited Financial Results For The Quarter And Year Ended March 31, 2024
Outcome of Board Meeting - Audited Financial Results for the quarter and year ended March 31, 2024 DR.REDDY'S LABORATORIES LTD. - 500124 - Outcome Of Board Meeting - Audited Financial Results For The Quarter And Year Ended March 31, 2024
Audited Financial results for the quarter and year ended March 31, 2024 DR.REDDY'S LABORATORIES LTD. - 500124 - Grant Of Employee Stock Options
Grant of Employee Stock options Dr Reddy'slaunches Doxycycline capsules in the US
The drug is atherapeutic generic equivalent of ORACEA (doxycycline, USP) capsules DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate(s) DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation under Regulation 30 DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30
Intimation under Regulation 30